Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia

References

• World Health Organization. Global tuberculosis report: 2019.
   Google Scholar
• Chheng P, Tamhane A, Natpratan C, et al. Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia. Int J Tuberculosis Lung Dis. 2008;12(3):S54–S62.
   Web of Science ®Google Scholar
• World Health Organization. Global World Tuberculosis Report 2017. Geneva, Switzerland: World Health Organization; 2017.
   Google Scholar
• Diarra B, Goita D, Tounkara S, et al. Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014. BioMed Central Infect Dis. 2016;16(1):714. doi:10.1186/s12879-016-2060-7
   Web of Science ®Google Scholar
• Alebachew Z, Kebede A, Tsegaye F. First Ethiopian National Population Based Tuberculosis Prevalence Survey; 7 2011.
   Google Scholar
• Keflie TS, Samuel A, Woldegiorgis AZ, Mihret A, Abebe M, Biesalski HK. Vitamin A and zinc deficiencies among tuberculosis patients in Ethiopia. J Clin Tuberculosis Other Mycobacterial Dis. 2018;12:27–33. doi:10.1016/j.jctube.2018.05.002
   Google Scholar
• Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to debre markos referral hospital, Ethiopia: a cross-sectional study. BioMed Central Res Notes. 2017;10(1):8.
   Google Scholar
• Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BioMed Central Infect Dis. 2019;19(1):307. doi:10.1186/s12879-019-3943-1
   Web of Science ®Google Scholar
• Belay M, Bjune G, Abebe F. Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, northeast Ethiopia. Glob Health Action. 2015;8(1):27949. doi:10.3402/gha.v8.2794926689454
   PubMed Web of Science ®Google Scholar
• Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at university of gondar hospital, northwest Ethiopia. Infect Drug Resist. 2017;10:185. doi:10.2147/IDR.S13593528652786
   PubMed Web of Science ®Google Scholar
• Nugussie DA, Mohammed GA, Tefera AT. Prevalence of smear-positive tuberculosis among patients who visited saint paul’s specialized hospital in Addis Ababa, Ethiopia. Biomed Res Int. 2017;2017:1–5. doi:10.1155/2017/6325484
   Web of Science ®Google Scholar
• Gebrecherkos T, Gelaw B, Tessema B. Smear positive pulmonary tuberculosis and HIV co-infection in prison settings of North Gondar Zone, Northwest Ethiopia. BioMed Central Public Health. 2016;16(1):1091. doi:10.1186/s12889-016-3761-y27756279
   PubMed Web of Science ®Google Scholar
• Gizachew Beza M, Hunegnaw E, Tiruneh M. Prevalence and associated factors of tuberculosis in prisons settings of East Gojjam Zone, Northwest Ethiopia. Int j Bacteriol. 2017;2017:1–7. doi:10.1155/2017/3826980
   Google Scholar
• Tulu B, Dida N, Kassa Y, Taye B. Smear positive pulmonary tuberculosis and its risk factors among tuberculosis suspect in South East Ethiopia; a hospital based cross-sectional study. BioMed Central Res Notes. 2014;7(1):285.
   Google Scholar
• Mama M, Manilal A, Tesfa H, Mohammed H, Erbo E. Prevalence of pulmonary tuberculosis and associated factors among HIV positive patients attending antiretroviral therapy clinic at Arba Minch general hospital, southern Ethiopia. Open Microbiol J. 2018;12(1):163. doi:10.2174/187428580181201016329997701
   PubMedGoogle Scholar
• Ejeta E, Beyene G, Bonsa Z, Abebe G. Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high human immunodeficiency virus setting in gambella regional state, southwest ethiopia. J Clin Tuberculosis Other Mycobacterial Dis. 2018;12:14–20. doi:10.1016/j.jctube.2018.06.002
   Google Scholar
• Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BioMed Central Res Notes. 2012;5(1):331.
   Google Scholar
• Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection—associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(Supplement_3):S201–S7. doi:10.1086/65149220397949
   PubMed Web of Science ®Google Scholar
• Parrish NM, Carroll KC. Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings. J Clin Microbiol. 2011;49(3):772–776. doi:10.1128/JCM.02451-1021177899
   PubMed Web of Science ®Google Scholar
• Taddese B, Desalegn D, Misganaw A, Kitila K, Balcha H. Comparison of GeneXpert against light-emitting diode fluorescent microscopy for the diagnosis of pulmonary tuberculosis in addis Ababa, Ethiopia. J Microbiol Biochem Technol. 2018;10(1):12–15. doi:10.4172/1948-5948.1000388
   Google Scholar
• Khan AS, Ali S, Khan MT, et al. Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan. Braz j Microbiol. 2018;49(4):909–913. doi:10.1016/j.bjm.2018.02.01129752010
   PubMed Web of Science ®Google Scholar
• Habte D, Melese M, Hiruy N, et al. The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases. Int J Infect Dis. 2016;49:179–184. doi:10.1016/j.ijid.2016.07.00227401584
   PubMed Web of Science ®Google Scholar
• Mechal Y, Benaissa E, Benlahlou Y, et al. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis. BioMed Central Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-018-3567-x
   Web of Science ®Google Scholar
• World Health Organization. Xpert MTB/RIF implementation manual: technical and operational ‘how-to’; practical considerations. World Health Organization; 2014: 9241506709.
   Google Scholar
• Ikuabe PO, Ebuenyi ID. Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Pan Afr Med J. 2018;29.
   Google Scholar
• Semunigus T, Tessema B, Eshetie S, Moges F. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in dessie and debre birhan towns, Northeast Ethiopia. Ann Clin Microbiol Antimicrob. 2016;15(1):50. doi:10.1186/s12941-016-0165-x27581729
   PubMed Web of Science ®Google Scholar
• Eliso E, Medhin G, Belay M. Prevalence of smear positive pulmonary tuberculosis among outpatients presenting with cough of any duration in Shashogo Woreda, Southern Ethiopia. BioMed Central Public Health. 2015;15(1):112. doi:10.1186/s12889-015-1411-425879547
   PubMed Web of Science ®Google Scholar
• Sinshaw W, Kebede A, Bitew A, et al. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. BioMed Central Infect Dis. 2019;19(1):641. doi:10.1186/s12879-019-4241-7
   Web of Science ®Google Scholar
• Teweldemedhin M, Asres N, Gebreyesus H, Asgedom SW. Tuberculosis-Human Immunodeficiency Virus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BioMed Central Infect Dis. 2018;18(1):676. doi:10.1186/s12879-018-3604-9
   Web of Science ®Google Scholar
• Mesfin EA, Beyene D, Tesfaye A, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018;13(6):e0197737. doi:10.1371/journal.pone.019773729864118
   PubMed Web of Science ®Google Scholar
• Berju A, Haile B, Nigatu S, Mengistu A, Birhan G. Smear-positive tuberculosis prevalence and associated factors among pregnant women attending antenatal care in north gondar zone hospitals, Ethiopia. Int J Microbiol. 2019;2019.
   Web of Science ®Google Scholar
• Hiruy N, Melese M, Habte D, et al. Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test. Int J Infect Dis. 2018;71:4–8. doi:10.1016/j.ijid.2018.03.01129559367
   PubMed Web of Science ®Google Scholar
• Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health. 2019;41.
   Web of Science ®Google Scholar
• Diandé S, Badoum G, Combary A, et al. Multidrug-resistant tuberculosis in Burkina Faso from 2006 to 2017: results of national surveys. Eur J Microbiol Immunol (Bp). 2019;9(1):23–28. doi:10.1556/1886.2018.0002930967972
   PubMedGoogle Scholar
• Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health. 2017;75(1):37. doi:10.1186/s13690-017-0204-x28835818
   PubMed Web of Science ®Google Scholar
• Hargreaves N, Kadzakumanja O, Phiri S, et al. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int j Tuberculosis Lung Dis. 2001;5(2):113–122.
   Web of Science ®Google Scholar
• Diallo A, Dahourou DL, Tassembedo S, Sawadogo R, Meda N, Meda N. Factors associated with tuberculosis treatment failure in the Central East Health region of Burkina Faso. Pan Afr Med J. 2018;30(1). doi:10.11604/pamj.2018.30.293.15074
   Web of Science ®Google Scholar